Purpose; Formation. Within [***] days after the Effective Date, the Parties will establish a joint steering committee (the “JSC”) that will monitor and provide strategic oversight of the activities under this Agreement and facilitate communications between the Parties with respect to the Research, Development, Manufacture and Commercialization of Antibody Candidates and Licensed Products, all in accordance with this Section 2.2.
Appears in 4 contracts
Sources: Collaboration Agreement (Coherus BioSciences, Inc.), Collaboration Agreement (Surface Oncology, Inc.), Collaboration Agreement (Surface Oncology, Inc.)
Purpose; Formation. Within [***] days after the Effective Date, the Parties will establish a joint steering committee (the “JSC”) that which will monitor and provide strategic oversight of the activities under this Agreement and facilitate communications between the Parties with respect to the Research, Development, Manufacture and Commercialization of Antibody Research Candidates, Development Candidates and Licensed Products, all in accordance with this Section 2.24.2.
Appears in 2 contracts
Sources: Collaboration Agreement (Unum Therapeutics, Inc.), Collaboration Agreement (Unum Therapeutics, Inc.)
Purpose; Formation. Within [***] days after of the Effective Date, the Parties will shall establish a joint steering committee (the “"JSC”) that will monitor "). The JSC shall monitor, make decisions, and provide strategic oversight of the activities under this Agreement and facilitate communications between the Parties with respect to the Research, Development, Manufacture and Commercialization of Antibody Candidates the Compounds and Licensed Products, all in accordance with this Section 2.2.
Appears in 2 contracts
Sources: Collaboration and License Agreement (Pliant Therapeutics, Inc.), Collaboration and License Agreement (Pliant Therapeutics, Inc.)
Purpose; Formation. Within [***] days after the Effective Date, Date the Parties will establish a joint steering committee (the “JSC”) that will monitor and provide strategic oversight of the activities under this Agreement and facilitate communications communication between the Parties Parties, in each case, with respect to the Research, Development, Manufacture Development and the Commercialization of Antibody Candidates the Collaboration Materials and Licensed ProductsCollaboration Product(s), all as applicable, in accordance with the terms of this Section 2.2Agreement.
Appears in 1 contract
Sources: Collaboration, Option, and License Agreement (Acumen Pharmaceuticals, Inc.)